secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0000950170-24-073501
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bolt Biotherapeutics annual meeting elects directors and ratifies auditor
-------------------------------------------------------------------------

- Director Kathleen LaPorte elected with 12,706,287 votes for, 3,990,176 withheld, 9,231,722 broker non-votes.
- Director Nicole Onetto elected with 12,819,050 votes for, 3,880,294 withheld, 9,228,841 broker non-votes.
- Ratification of PricewaterhouseCoopers LLP as auditor for FY2024: 23,736,566 for, 2,032,686 against, 158,933 abstaining.
- Total shares represented at meeting: 25,928,185 of 38,127,740 shares entitled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000095017024073501/0000950170-24-073501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000095017024073501/bolt-20240612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-073501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer